Physical activity and the Neuro-Immuno-Fascial interface in cancer patients: mechanisms, clinical evidence, and therapeutic integration.
Physical activity has progressed from supportive care to an evidence-based oncologic intervention, with large cohort studies showing dose-dependent reductions in all-cause cancer mortality of roughly 20-47% across multiple tumor entities, and randomized trial evidence supporting a pooled reduction of approximately 26%. The CCTG CO.21 CHALLENGE trial, the first randomized controlled trial powered for survival endpoints, demonstrated that structured post-adjuvant exercise …












